[ad_1] Dana Inc DAN reported first-quarter FY23 sales growth of 7% year-on-year to $2.64 billion, beating the consensus of $2.56 billion. The revenue increase was driven by

[ad_1] At the second edition of Benzinga’s Psychedelics Capital Conference, held in sunny Miami, leaders from four major ketamine therapy companies shared their optimistic insights

[ad_1] KeyBanc Capital Markets on Monday adjusted its ratings on several Cable and Wireless stocks after analyzing first-quarter conferences and engaging in discussions with key

[ad_1] Commercial Metals Co CMC reported second-quarter FY23 sales of $2.02 billion, a slight increase of 0.5% year-over-year, which beat the consensus of $1.97 billion. Sales

[ad_1] Clinical-stage biopharma company Mind Medicine (MindMed), Inc. MNMD shared its financial results for the full year ended Dec. 31, 2022. Numbers show solid stability:

[ad_1] Freshpet Inc FRPT reported fourth-quarter FY22 sales growth of 43.1% year-on-year, to $165.83 million, beating the consensus of $152.11 million. The company attributed the sales

[ad_1] Generac Holdings Inc GNRC reported a fourth-quarter FY22 sales decline of 2% year-on-year to $1.05 billion, missing the consensus of $1.07 billion. Residential product sales

[ad_1] Church & Dwight Co Inc CHD reported fourth-quarter FY22 sales growth of 5% year-on-year to $1.44 billion, beating the consensus of $1.40 billion. Organic sales